Glucocorticoid inhibit the proliferation of lymphoid cells of thymic origin. This process is involved in thymic involution during normal thymic development. Malignant T lymphoma and leukemia cells are also subject to growth arrest by glucocorticoid, and such steroids are widely used in chemotherapy of lymphoproliferative diseases. A rational approach to the chemotherapeutic effects of glucocorticoid requires that we understand the mechanisms whereby such hormones regulate lymphoid cell proliferation. Our working hypothesis states that two distinct mechanisms prevail. One is cytolysis, which appears to be attributable to induction or activation of nucleases that degrade the nuclear DNA. Variants have been isolated that are resistant to the cytolytic effects of glucocorticoid in vivo. These express fully functional receptors. It is proposed that these are variants in glucocorticoid-mediated DNA degradation or repair. To test this hypothesis, experiments will be carried out to estimate the relative rates of DNA damage and repair in wild type P1798 cells and those variants that do not express the cytolytic phenotype. Glucocorticoid can also inhibit the proliferation of P1798 cells in the absence of a cytolytic response. This indicates that cytolysis and inhibition of proliferation are distinct phenomena. It is proposed that inhibition of proliferation is due to inhibition of expression of certain genes that are critical for progression through the cell cycle. Glucocorticoid inhibition of gene expression is poorly understood. A series of experiments is proposed to study mechanisms of inhibition. The major emphasis will be to understand regulation of the gene encoding thymidine kinase (TK). TK is subject to secondary inhibition of transcription. Experiments will be carried out to test the hypothesis that this is due to hormonal regulation of factors that are required for transcription of TK. A parallel series of experiments will be carried out to study the mechanism whereby glucocorticoid inhibit transcription of c-myc in P1798 cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA024347-11
Application #
3481975
Study Section
Endocrinology Study Section (END)
Project Start
1987-08-01
Project End
1993-05-31
Budget Start
1989-06-01
Budget End
1990-05-31
Support Year
11
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Chen, Lu; Necela, Brian M; Su, Weidong et al. (2006) Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2. J Biol Chem 281:24575-87
Chen, Lu; Bush, Craig R; Necela, Brian M et al. (2006) RS5444, a novel PPARgamma agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells. Mol Cell Endocrinol 251:17-32
Chen, Lu; Finnerty, Celeste; Gustafson, William C et al. (2003) Genomic analysis of glucocorticoid-regulated promoters in murine T-lymphoma cells. Recent Prog Horm Res 58:155-74
Murray, Nicole R; Weems, Capella; Chen, Lu et al. (2002) Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis. J Cell Biol 157:915-20
Ma, T; Copland, J A; Brasier, A R et al. (2000) A novel glucocorticoid receptor binding element within the murine c-myc promoter. Mol Endocrinol 14:1377-86
Bresnahan, W A; Albrecht, T; Thompson, E A (1998) The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J Biol Chem 273:22075-82
Bresnahan, W A; Thompson, E A; Albrecht, T (1997) Human cytomegalovirus infection results in altered Cdk2 subcellular localization. J Gen Virol 78 ( Pt 8):1993-7
Ramalingam, A; Hirai, A; Thompson, E A (1997) Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1. Mol Endocrinol 11:577-86
Bresnahan, W A; Boldogh, I; Chi, P et al. (1997) Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239-47
Ehrenfried, J A; Ko, T C; Thompson, E A et al. (1997) Cell cycle-mediated regulation of hepatic regeneration. Surgery 122:927-35

Showing the most recent 10 out of 28 publications